Literature DB >> 33226329

A study of the use of Behçet/Behçet's disease or syndrome with or without Adamantiades in the medical literature during the past two decades.

Yaşar Barış Turgut1, Gökhan Sargın2.   

Abstract

OBJECTIVE: Medical literature shows that some authors tend to use the eponym Behçet/Behçet's disease/syndrome, whereas others use its amalgamated form, that is, Adamantiades-Behçet/Behçet's disease/syndrome. We investigated the changes in the use of these eponyms over the past 2 decades.
METHODS: We used the PubMed database to search for publications that contained any of these nomenclatures using the appropriate tools available. Data were obtained for the title evaluated in the database and variations of the title or its distribution by year with respect to the nomenclature found in most related studies.
RESULTS: A total of 4,211 publications were found to use the original eponym compared with 96 publications that included the term Adamantiades from the year 2000 to the present. Considering the title of the articles, there was a declining use of the amalgamated form with Adamantiades from the first decade to the second decade, whereas there was an increasing use of Behçet/Behçet's disease or syndrome. In contrast, the relative percentages of all the reviewed articles that used the eponym disease or syndrome (without the amalgamated form) published in different specialty journals (rheumatology, ophthalmology, dermatology, and others) remained unchanged during the past 2 decades.
CONCLUSION: The general trend was to use Behçet/Behçet's disease or syndrome alone, although many scientists have contributed to the literature related to this topic during the historical period. The contributions of these scientists are undeniably significant, and honoring their importance is paramount.

Entities:  

Year:  2020        PMID: 33226329      PMCID: PMC8133883          DOI: 10.5152/eurjrheum.2020.20095

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  19 in total

1.  Some historical notes on Behçet's disease.

Authors:  T O Cheng
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

2.  A historical review of early descriptions of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Wolfgang Keitel
Journal:  J Invest Dermatol       Date:  2002-07       Impact factor: 8.551

3.  Description of Behçet's syndrome in the Hippocratic third book of endemic diseases.

Authors:  A FEIGENBAUM
Journal:  Br J Ophthalmol       Date:  1956-06       Impact factor: 4.638

4.  Neurological symptoms of Adamantiades-Behçet's syndrome.

Authors:  J M S Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

5.  All medical eponyms should be abandoned.

Authors:  Eric L Matteson
Journal:  Presse Med       Date:  2007-12-27       Impact factor: 1.228

6.  Thirty neurological eponyms associated with the nazi era.

Authors:  Daniel Kondziella
Journal:  Eur Neurol       Date:  2009-04-30       Impact factor: 1.710

7.  2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Authors:  Gulen Hatemi; Robin Christensen; Dongsik Bang; Bahram Bodaghi; Aykut Ferhat Celik; Farida Fortune; Julien Gaudric; Ahmet Gul; Ina Kötter; Pietro Leccese; Alfred Mahr; Robert Moots; Yesim Ozguler; Jutta Richter; David Saadoun; Carlo Salvarani; Francesco Scuderi; Petros P Sfikakis; Aksel Siva; Miles Stanford; Ilknur Tugal-Tutkun; Richard West; Sebahattin Yurdakul; Ignazio Olivieri; Hasan Yazici
Journal:  Ann Rheum Dis       Date:  2018-04-06       Impact factor: 19.103

8.  Hulusi Behçet (1889-1948): Passion for dermatology.

Authors:  Siang Yong Tan; Patricia Sims Poole
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

Review 9.  [Adamantiades-Behcet's disease].

Authors:  L Krause
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

10.  Medical eponyms.

Authors:  Robert P Ferguson; Deborah Thomas
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.